Literature DB >> 34338961

Effect of calcium dobesilate on retrobulbar blood flow and choroidal thickness in patients with non-proliferative diabetic retinopathy.

Hossein Ashraf1, Mehrzad Lotfi2, Maryam Akbari1, Hamidreza Jahanbani-Ardakani3,4, Morteza Ghaffari1, Mohammad Reza Khalili1.   

Abstract

INTRODUCTION: Diabetic retinopathy is one of the most common causes of blindness in work-aging adults and develops in one third of diabetic patients. Calcium dobesilate (CaD) treatment have protective effects on blood retinal barrier (BRB) and anti-oxidant as well as anti-inflammatory properties.
OBJECTIVES: To assess effects of CaD administration on retrobulbar blood flow and choroidal thickness in patients with diabetic retinopathy.
METHODS: In this quasi-experimental study, diabetic patients with diabetic retinopathy (DR) were recruited from Shahid Motahari and Poostchi ophthalmology clinic affiliated to Shiraz University of Medical Sciences. Patients were treated with CaD, 1 gr per day for seven days. Before and after CaD administration, retrobulbar blood flow and subfoveal choroidal thickness were assessed. Retrobulbar blood flow were evaluated by measuring peak systolic velocity (PSV), end diastolic velocity (EDV) and resistive index (RI) of ophthalmic artery (OA), central retinal artery (CRA) and short ciliary artery (SCA).
RESULTS: In this study, 26 DR patients with a mean age of 56.15 ± 8.93 years and mean diabetes mellitus duration of 15.04 ± 7.64 years were enrolled. Subfoveal choroidal thickness was significantly increased from 316.08 ± 61.69 to 327.81 ± 58.03 after CaD treatment (P value < 0.001). PSV of CRA and EDV of all arteries were significantly increased after CaD administration. In addition, RI of all arteries was significantly reduced after CaD treatment (P < 0.001).
CONCLUSION: CaD treatment may improve the ophthalmic blood flow and increase the subfoveal choroidal thickness in DR patients. These results may be suggestive of protective effects of CaD on endothelium function as well as microvascular circulation.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Calcium dobesilate; Choroidal thickness; Doxium; Non-proliferative diabetic retinopathy; Retrobulbar blood flow

Year:  2021        PMID: 34338961     DOI: 10.1007/s10792-021-01914-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  26 in total

1.  Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy.

Authors:  Yan Cui; Xun Xu; Hongsheng Bi; Qi Zhu; Jianfeng Wu; Xin Xia; Patrick C P Ho
Journal:  Exp Eye Res       Date:  2006-06-05       Impact factor: 3.467

2.  Effect of adding oral calcium dobesilate to laser photocoagulation on the macular thickness in patients with diabetic macular edema: a randomized clinical trial.

Authors:  Mostafa Feghhi; Fereydoun Farrahi; Mohammadreza Abbaspour; Akbar Takhtaeian
Journal:  Adv Pharm Bull       Date:  2014-08-10

Review 3.  Diabetic retinopathy.

Authors:  Ning Cheung; Paul Mitchell; Tien Yin Wong
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

4.  A controlled clinical trial of calcium dobesylate in the treatment of diabetic retinopathy.

Authors:  J C Daubresse; R Meunier; P Dumont
Journal:  Diabete Metab       Date:  1977-03

5.  Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.

Authors:  I S Benarroch; M Brodsky; A Rubinstein; C Viggiano; E A Salama
Journal:  Ophthalmic Res       Date:  1985       Impact factor: 2.892

6.  Mapping choroidal thickness in patients with type 2 diabetes.

Authors:  Beatriz Abadia; Francisco de Asís Bartol-Puyal; Pilar Calvo; Guayente Verdes; Carlos Isanta; Luis E Pablo
Journal:  Can J Ophthalmol       Date:  2019-08-09       Impact factor: 1.882

7.  Choroidal thinning in diabetes type 1 detected by 3-dimensional 1060 nm optical coherence tomography.

Authors:  Marieh Esmaeelpour; Simon Brunner; Siamak Ansari-Shahrezaei; Siamak Ansari Shahrezaei; Susanne Nemetz; Boris Povazay; Vedran Kajic; Wolfgang Drexler; Susanne Binder
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-03       Impact factor: 4.799

8.  [Effect of calcium dobesilate on progression of diabetic retinopathy].

Authors:  A Haas; G Trummer; M Eckhardt; O Schmut; I Uyguner; K P Pfeiffer
Journal:  Klin Monbl Augenheilkd       Date:  1995-07       Impact factor: 0.700

Review 9.  Role of oxidative stress, inflammation, hypoxia and angiogenesis in the development of diabetic retinopathy.

Authors:  Abdullah S Al-Kharashi
Journal:  Saudi J Ophthalmol       Date:  2018-05-29

10.  Choroidal thickness measured using swept-source optical coherence tomography is reduced in patients with type 2 diabetes.

Authors:  Beatriz Abadia; Ines Suñen; Pilar Calvo; Francisco Bartol; Guayente Verdes; Antonio Ferreras
Journal:  PLoS One       Date:  2018-02-02       Impact factor: 3.240

View more
  1 in total

1.  Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology.

Authors:  Bingyu Du; Yanyan Yin; Yuqing Wang; Hui Fu; Helin Sun; Zhaodi Yue; Shaohong Yu; Zhongwen Zhang
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.